How We Measure Outcomes

Information presented reflects outcomes from 56 clients who completed exposure-based therapy between 2023 and 2026. Symptom severity was tracked using standardized clinical measures tailored to each client’s primary concern, including OCD, panic disorder, emetophobia, trauma-related fear, and other phobias.  Clinical improvement was defined as a ≥35%. Across all measures, the median reduction in symptom severity was 50% over a median course of 160 days of care. Individual results vary and past outcomes do not guarantee future results.